Patients with SARS-CoV-2 infection (COVID-19) risk developing long-term neurologic
symptoms after infection. Here, we identify biomarkers associated with neurologic sequelae
one year after hospitalization for SARS-CoV-2 infection. SARS-CoV-2-positive patients were
followed using post-SARS-CoV-2 online questionnaires and virtual visits. Hospitalized
adults from the pre-SARS-CoV-2 era served as historical controls. 40% of hospitalized
patients develop neurological sequelae in the year after recovery from acute COVID-19 …

Background: Patients with SARS-CoV-2 infection (COVID-19) risk developing long-term
neurologic symptoms after infection, though risk factors and mechanisms for this
phenomenon remain largely unknown. This study seeks to identify biomarkers associated
with neurologic sequelae in patients after hospitalization for SARS-CoV-2 infection.
Methods: Plasma samples, sociodemographic information, clinical outcome data, and
baseline laboratory information were retrospectively analyzed from an observational cohort …